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We evaluated the antidiabetic and antioxidant activity of Dodonaea viscosa 
in streptozotocin-induced diabetic rats. The water extract (DVW) and polar 
fraction of ethanol extract (DVE-4) in a single-dose one-day study showed 
dose-dependent reduction in glucose levels with maximum effect of 42.16% 
and 72.9% respectively at 6 h post drug treatment (p<0.001). DVE-4 was 
more active than DVW and glibenclamide. In a multi-dose fifteen-day study, 
lower doses of DVW (400 mg/kg) and DVE-4 (200 mg/kg) exhibited higher 
percentage reduction in glucose levels compared to glibenclamide treated 
group. Altered levels of lipids, TBARS, non-enzymatic and enzymatic 
antioxidants were restored by DVW (400 mg/kg) and DVE-4 (200 mg/kg) in 
diabetic rats. In vitro steady state and time resolved studies reveled that DVW 
and DVE-4 showed comparable antioxidant ability in steady state and kinetic 
studies suggesting its possible role in observed antidiabetic and 
hypolipidaemic activities. 
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Diabetes mellitus is a multifaceted, dynamic 
expression of pathological disequilibria, resulting 
in various micro and macro vascular 
complications. Large numbers of people around 
the world suffering from diabetes especially over 
the past two decades, from 30 million to 230 
million [1]. Oxidation and production of free 
radicals are an integral part of normal cell 
metabolism. An imbalance between reactive 
oxygen species (ROS) and the antioxidant 
defense mechanisms (Enzymatic and non-
enzymatic) of a cell leads to excessive production 
of   oxygen   metabolites,   creating   a   condition  
 
frequently termed as ‘oxidative stress’ [2]. 
Excessive oxidative stress has been implicated in 
the pathology and complications of diabetes 
mellitus [3]. The increased blood glucose levels 
in diabetes produce superoxide anions, which 
generate hydroxyl radicals via Haber-Weiss 
reaction,  resulting in peroxidation of membrane 
lipids and protein glycation. This leads to 
oxidative damage to cell membranes. These 
radicals further damage other important 
biomolecules including carbohydrates, proteins 
and DNA [4].  
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Streptozotocin (STZ) selectively destroy β-cells 
of pancreas by generating excess ROS and 
carbonium ion (CH3+) leading to DNA breaks by 
alkylating DNA bases. The N-nitroso-N methyl 
urea portion of the molecule exhibits 
diabetogenic activity. Glucose may act as carrier 
for this cytotoxic group [5]. 
Evaluation of plant products to treat diabetes 
mellitus is of growing interest as they contain 
many bioactive substances with therapeutic 
potential. Dodonaea viscosa (L). Jacq., (Family: 
Sapindaceae) popularly known as aliar and 
vilayati mehandi in India, is an evergreen shrub 
abundantly growing in Western Ghats of 
Karnataka, India. This species has been used in 
traditional ayurvedic system of medicine to heal 
simple ulcer, fracture [6], soreness, snakebite 
pain, relief of gum and teeth pain [7]. 
Experimental studies have demonstrated 
antimicrobial, anti-inflammatory [8], anti-ulcer 
[9], wound healing [10], local anaesthetic and 
smooth muscle relaxant activities of the title plant 
[11]. The hypoglycemic effect of the title plant is 
indicated by Aswal et al. while screening 294 
plants of Indian origin [12]. As a part of our 
preliminary work, we found both ethanol and 
water extracts (400-800 mg/kg) did not 
significantly reduce hyperglycemia induced by 
glucose load (2g/kg) in normal rats. However 
both the extracts showed reduction in blood 
glucose levels of STZ-induced diabetic rats 
indicating that they are active only in diabetic 
conditions. In literature no exhaustive scientific 
data regarding detailed antioxidant and 
antidiabetic effect of D. viscosa are available. In 
the present study, we addressed these points.  
 
Material and methods 
Experimental animals  
Male wistar rats 7-8 weeks old and weighing 
200-250g were used. The animals were obtained 
from the inbred animal colony of central animal 
house, Kasturba Medical College, MAHE, 
Manipal, India. The animals were maintained 
under controlled conditions of temperature (23 ± 
2°C), humidity (50 ± 5%) and 12-h light-dark 
cycles. The animals were randomized into 
experimental and control groups and housed two 
each in sanitized polypropylene cages containing 
sterile paddy husk as bedding. They had free 
access to standard pellets as basal diet and water 
ad libitum. All the animal studies conducted were 
approved by the Institutional Ethical Committee, 
Kasturba Medical College [vide letter # 
IAEC/KMC/06/2004-2005], Manipal, according 
to prescribed guidelines of Committee for the 
Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA), 
Government of India. 
 
Chemicals  
Streptozotocin (STZ), thiobarbituric acid (TBA), 
5,5’-dithio-bis-2-nitrobenzoic acid (DTNB, 
Ellman’s reagent), 1-chloro-2, 4-dinitrobenzene 
(CDNB), reduced glutathione (GSH), superoxide 
dismutase (SOD), 2,2-diphenyl-1-picrylhydrazyl 
(DPPH), 2,2’-azinobis(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS2-), ascorbic acid (ASC), 
Deoxy-D-ribose, egg phospatidylcholine, 
nicotinamide adenine dinucleotide (NADH), 
nitroblue tetrazolium (NBT), butylated 
hydroxytoluene (BHT), butylated hydroxyl 
anisole (BHA) and calf thymus DNA were 
purchased form Sigma chemical Co, USA. 
Mannitol was procured from SD fine chemicals, 
Mumbai, India. Trolox and phenazine 
methosulphate (PMS) were procured from 
Himedia, Mumbai, India. All chemicals used 
were of analytical grade. IOLAR grade nitrogen 
and N2O were used for degassing the samples. 
Nanopure water from Millipore Milli-Q system 
was used for preparing solutions and all solutions 
were prepared fresh.  
 
Plant material  
The whole plant of Dodonaea viscosa was 
collected in and around Dharwad, Karnataka 
during the month of September 2006. The plant 
was authenticated by Prof. M. Jayaraj, 
Department of Botany, Karnataka University, 
Dharwad and voucher specimen 
(#MCOPS/PC/05/06) of the plant was kept in the 
college herbarium. 
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Extraction and fractionation  
The shade dried and coarse powdered material (1 
kg) was extracted exhaustively with ethanol in a 
soxhlet apparatus, subsequently extracted with 
water on a hot water bath. The extracts were 
concentrated to a small volume and evaporated to 
dryness in a vacuum desiccator (Osworld, J.R 
industrial corporation, Mumbai) to yield free 
flowing ethanol extract [DVE] (Herb: extract = 5) 
and water extract [DVW] (Herb: extract = 8).  
Dried DVE (246 g) was fractionated by 
adsorptive solvent extraction method. Briefly, 
extract was dissolved in ethanol (200 ml) and 
adsorbed onto silica gel (120#) and air-dried. 
Extract coated silica gel was extracted 
successively using solvents of increasing polarity 
(4×400 ml each) to yield the following fractions 
of different polarities: [1] Petroleum ether (60-80 
C) [DVE-1; yield 52.8 g], [2] Chloroform [DVE-
2; yield 35.4 g], [3] Ethyl acetate [DVE-3; yield 
64.3 g] and [4] Methanol [DVE-4; yield 89.4 g].  
 
Acute toxicity studies  
Healthy male wistar rats, starved overnight (12 
h), were divided into 18 groups of 6 each and were 
orally fed with increasing doses (10, 30, 100, 300, 
1000 and 3000mg/kg) of DVW, DVE and DVE-4 
were studied to determine the safe doses by up 
and down staircase method. The animals were 
observed continuously for one hour, then 
frequently for 4 hours and later at the end of 24 h. 
After administration of the drug, Irwin test was 
conducted, where the animals were observed for 
behavioral changes. Further, animals were 
observed daily for 30 days, and mortality was 
recorded [13]. To know multiple dose toxicity of 
extract/fraction, highest dose was fed once daily 
for 15 days and observed for incidences of 
mortality for a period of 30 days.  
 
Induction of diabetes mellitus  
Diabetes mellitus was induced in wistar rats by 
single intraperitoneal injection of freshly 
prepared solution of STZ (45mg/kg body weight) 
in 0.1M citrate buffer of pH 4.5, in a volume of 3 
ml/kg after overnight fasting for 12 h [14]. Rats 
showing blood glucose level > 200 mg/dl 72 h 
after STZ administration were considered 
diabetic and included in the study. Diabetic rats 
were randomized into different groups based on 
their blood glucose levels. Glibenclamide was 
used as positive control in all the protocols 
described below.      
Protocol 1: The effect of single oral dose of 400 
mg/kg of DVE and DVW on hyperglycemia at 
different time intervals was studied in 12 h fasted 
STZ-induced diabetic animals (5 groups of 5 
animals each). Blood samples were collected 
from the caudal vein by means of a small incision 
at the end of the tail at 0, 2, 4, 6 and 10 h after 
drug administration (single-dose one-day study). 
Blood glucose was estimated by the enzymatic 
glucose oxidase method using a commercial 
glucometer (Accu-chek® Active, Roche 
diagnostic, Mannheim, Germany). Percentage 
reduction in glycemia was calculated with respect 
to the initial (0 h) level according to: percent 
reduction in glycemia = [(Gi-Gt)/Gi] x 100; 
Where Gi is initial glycemia and Gt is glycemia 




Figure 1. Effect of DVW and DVE-4 on Serum 
glucose levels in STZ induced diabetic rats 
[Single dose one-day study]. Bar graph 
represents the percentage reduction in glycaemia 
with respect to the initial (0 h) level. Each bar 
represent mean ± S.E.M; N=5 in each group, a 
p<0.05, b p<0.01, c p<0.001 compared to diabetic 
control of the same time interval. 
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The above groups of animals were further treated 
with single daily doses for another 15 days in 
order to evaluate the chronic effect of DVW and 
DVE treatment on hyperglycemia (Multiple-dose 
fifteen-day study). Blood glucose was estimated 
on days 0, 7, 10 and 15 by the enzymatic glucose 
oxidase method using a commercial glucometer. 
Percentage reduction in glycemia was calculated 
with respect to the initial (0 day) level.   
Protocol 2: As described in protocol 1, the effect 
of single oral dose administration of DVE-2 to 
DVE-4 at 400 mg/kg was studied (6 groups of 5 
animals each). DVE-4 was found to be more 
active, and therefore was further administered 
once daily for 15 days and percent reduction in 
glycemia was evaluated.  
Protocol 3:  Effect of different doses of DVW 
(400 and 800 mg/kg) and DVE-4 (200 and 400 
mg/kg) were studied as described in protocol 1 (7 
groups of 5 animals each).   
Estimation of biochemical parameters: At the end 
of 15 days of treatment, the animals (protocol 1 
to 3) were fasted overnight and blood samples 
were collected from retro-orbital plexus. Serum 
was separated and analysed 
spectrophotometrically for triglyceride, 
cholesterol, HDL-cholesterol (HDL-c), using 
diagnostic reagent kit (Nicholas piramal India 
Ltd., Mumbai). VLDL-cholesterol (VLDL-c) and 
LDL-cholesterol (LDL-c) in serum were 
calculated as per Friedewald’s equation. VLDL-c 
= [TG/5]; LDL-c = [Total cholesterol – (TG/5) - 
HDL-c]. The markers of dyslipidemia such as 
TC/HDL-c and LDL-c/HDL-c ratios were also 
calculated. 
Animals were sacrificed by cervical dislocation, 
livers excised; reduced glutathione, total thiols, 
TBARS, GST, catalase and SOD were evaluated 
as described in our recent publication [16]. 
 
In vitro free radical scavenging studies  
Reaction with DPPH radical: For steady state 
measurements, 100 μM DPPH in methanol was 
added to DVW and DVE-4 (5-100 μg/ml) in 
methanol/water, mixed well and the absorbance 
was measured at 517 nm with or without the 
extracts as described earlier [17]. Kinetics of 
DPPH reaction with the DVW and DVE-4 was 
studied using stopped-flow kinetic spectrometer 
Model SX 18 MV (Applied Photophysics, UK) in 
single mixing mode using two syringes. In this 
experiment, syringe I contained 100 μM DPPH in 
methanol and syringe II contained solution of 
DVW and DVE-4 (26-260 μg/ml) (separately). 
With a time delay of 1.3 seconds, both the 
solutions in syringe I and II were mixed and the 
relative change in the absorbance at 517 nm as a 
function of time at 25°C was measured. Analysis 
of the kinetic traces was carried out with an 
exponential function using the built in software. 
At least three independent runs were used to 
determine the observed decay rate constant at 
different concentrations [18].  
Reaction with ABTS radical anion:  For steady 
state measurements, 100 μM ABTS•−  was mixed 
with DVW and DVE-4 (6.9-47 μg/ml) and the 
decrease in absorbance was measured at 734 nm 
as described earlier [17]. Kinetics of ABTS•− 
reaction with DVW and DVE-4 was also studied 
using stopped-flow spectrometer in single mixing 
mode. In this experiment, syringe I contained 200 
μM ABTS•− in methanol and syringe II contained 
solution of DVW and DVE-4 (26-260 μg/ml) 
(separately). Time dependent absorbance changes 
at 645 nm were measured [19]. 
Reaction with hydroxyl radical: Steady state •OH 
scavenging activity of DVW and DVE-4 (34-667 
μg/ml) was measured by degradation of deoxy-D-
ribose method [20]. Reaction of DVW and DVE-
4 with •OH was carried out using nanosecond 
pulse radiolysis technique employing high-energy 
electron pulses (50ns, 7MeV) obtained from a 
linear electron accelerator and the transients 
detected by kinetic spectrometry [21]. 
Competition kinetics of •OH scavenging by 
DVW and DVE-4 against 250 μM KSCN at pH 
6.8 were studied by monitoring (SCN)2•− 
absorbance at 500 nm [22]. 
Lipid peroxidation assay: The ability of DVW 
and DVE-4 (25-125 μg/ml) to inhibit Fe3+-ASC 
induced lipid peroxidation was studied using 
phosphatidylcholine liposomes with Trolox as a 
reference standard [19].   
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Reaction with superoxide radical anion: 
Superoxide radical anion are generated in PMS-
NADH systems by oxidation of NADH and 
assayed by the reduction of NBT to blue 
formazan. The effect of different concentration 
(29-581 μg/ml) of DVW and DVE-4 was studied 
as described earlier [23].  
Total antioxidant capacity:  The total antioxidant 
assay based on the reduction of molybdate-VI 
(MoVI) to molybdate-V (MoV) by DVW and 
DVE-4. This was done to study the activity, 
expressed as the number of equivalents of 
ascorbic acid (ASC) using standard plot [24].   
Calf thymus DNA Protection studies:  Effect of 
DVW and DVE-4 (800μg/ml) on Fenton 
reaction-induced calf thymus DNA damage was 
studied and the protection was assessed under 
transilluminated UV light [24].  
  
 
Fig. 2. Effect of DVW and DVE-4 on Serum 
glucose levels in STZ induced diabetic rats 
[Multidose fifteen-day study]. Bar graph 
represents the percentage reduction in glycaemia 
with respect to the initial (day ‘0’) level. Each bar 
represent mean ± S.E.M; N=5 in each group, a 
p<0.05, b p<0.01, c p<0.001 compared to diabetic 
control of the same time interval. 
 
Statistical evaluation  
The data was expressed as mean ± S.E.M. 
Statistical comparisons were performed by one-
way analysis of variance (ANOVA) followed by 
Tukey’s post-test using GraphPad Prism version 
4.00. The results were considered statistically 
significant if the p-values were 0.05 or less. 
 
Results 
Acute toxicity studies  
Animals showed good tolerance to testing single 
doses of extracts/fractions in doses as high as 3 
g/kg were found to be non-lethal. Highest studied 
doses extracts/fractions did not produce any 
noticeable signs of toxicity and mortality after 




Figure 3. Estimation of non-enzymatic 
antioxidants and TBARS in the liver 
homogenates of normal and experimental 
diabetic animals [Multidose fifteen-day study]. 
Each bar represent mean ± S.E.M; N=5 in each 
group, bp<0.01 compared to diabetic control 
(ANOVA followed by Tukey’s post-test). 
 
Antidiabetic studies 
Protocol 1: Single dose of DVW (400 mg/kg) 
exhibited greater hypoglycemic activity than 
DVE (400 mg/kg) in STZ-induced diabetic rats. 
DVW treatment significantly (p<0.05 to p<0.001) 
reduced blood glucose levels at different time 
intervals as compared to diabetic control group. 
The maximum reduction in glucose levels 
(21.4%) was observed 6 h after administration of 
DVW (Figure 2). Repeated administration of 
DVE and DVW for 15 days, showed significant 
(p<0.001) reduction in blood glucose when 
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compared to diabetic control group.  Treatment of 
both DVE and DVW exhibited comparable 
hypoglycemia on 7th, 10th and 15th days to 
glibenclamide treated group (0.5 mg/kg) (Figure 
3). From the above data we found that DVW is 
most active. Further, DVE was also found to be 
active in multi-dose fifteen-day study. Therefore, 
DVE was subjected to bioactive fractionation.  
 
Table 1. Comparison of the IC50 in μg/ml of 
DVW and DVE-4 against various free radicals 
and their total antioxidant capacity. Standards 
used are ASC for 1 & 2 (2.78±0.09 and 
1.64±0.05 μg/ml respectively); Mannitol for 3 
(2950.0±3.5 μg/ml); BHA for 4 (1.46±0.17 
μg/ml); Trolox for 6 (7.99±0.2 μg/ml) 
 




















All values reported as Mean±S.E.M (n=3). 
 
Protocol 2: DVE-4 was found to be more active 
than all other tested fractions (DVE-2 to DVE-4) 
in single-dose one-day study (data was not 
significant for DVE-2 and DVE-3). DVE-4 (400 
mg/kg) exhibited significant (p<0.001) maximum 
reduction in glucose levels (72.9%) at 6 h post 
administration compared to diabetic control 
group. At the same time intervals, DVE-4 treated 
diabetic rats also showed higher hypoglycemic 
activity compared to DVW (21.4%) and 
glibenclamide (67.8%) treated groups (Figure 2). 
Maximum reduction (p<0.001) in blood glucose 
(41.7%) was observed on 10th day during the 15-
day single dose regime of DVE-4 (Figure 3). 
Protocol 3 was followed further to study dose-
response of DVW and DVE-4.  
Protocol 3: Acute DVW (400 and 800 mg/kg) 
and DVE-4 (200 and 400 mg/kg) treatment 
produced dose-dependent fall in blood glucose in 
STZ-induced diabetic rats (Figure 2). However, 
in a 15-day study, the activity was observed only 
up to a dose of 400 mg /kg of DVW and 200 
mg/kg of DVE-4. (Figure 3) 
Estimation of biochemical parameters: Serum 
triglyceride (TG), total cholesterol (TC), VLDL-c 
and LDL-c levels were significantly (p<0.001) 
increased whereas HDL-c was decreased in 
diabetic rats compared to normal rats. Treatment 
of diabetic rats with DVE (400 mg/kg), DVW 
(400 mg/kg) and DVE-4 (200 mg/kg) for 15 days 
resulted in marked decrease in serum TG, TC, 
VLDL-c and LDL-c levels and increase in HDL-c 
levels compared to diabetic control group (Table 




Figure 4. Estimation of enzymatic antioxidants 
in the liver homogenates of normal and 
experimental diabetic animals [Multidose 
fifteen-day study]. Each bar represent mean ± 
S.E.M; N=5 in each group, ap<0.05 and bp<0.01 
compared to diabetic control (ANOVA followed 
by Tukey’s post-test). 
 
The markers of dyslipidemia such as TC/HDL-c 
and LDL-c/HDL-c ratios were significantly 
elevated in the diabetic group with respect to the 
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control (Table 2) but supplementation of DVW 
(400 mg/kg) and DVE-4 (200 mg/kg) for 15 days 
resulted in a significant fall in these dyslipidemic 
markers, which were restored to near-normal 
values (Table 2). 
Endogenous antioxidant status: Non-enzymatic 
antioxidants such as reduced glutathione and total 
thiols were significantly (p<0.01) lower whereas 
TBARS levels were increased in untreated 
diabetic rats compared to normal rats. All tested 
extracts/fraction markedly ameliorated the 
deleterious effect of STZ.  DVW (400 mg/kg) 
and DVE-4 (200 mg/kg) treated diabetic rats 
showed significant (p<0.01) increase in reduced 
glutathione, total thiols and reduced TBARS 
compared to untreated diabetic rats (Figure 4). 
Enzymatic antioxidants such as GST, catalase 
and SOD were significantly (p<0.01) decreased 
in diabetic rats compared to normal rats. DVW 
(400 mg/kg) and DVE-4 (200 mg/kg) treated 
diabetic group showed significant increase in all 
the tested enzyme levels compared to diabetic 




Figure 5. Variations of kobs for DPPH decay at 
517 nm as a function of different 
concentrations of (a) DVW (b) DVE-4. Inset: 
absorption-time plot showing decay of 50 μM 
DPPH at 517nm in presence of (c) 112.5 μg/ml of 
DVW (d) 130 μg/ml of DVE-4. 
 
In vitro free radical scavenging studies 
Reaction with DPPH radical: DVW and DVE-4 
were found to show DPPH (50μM) scavenging 
activity under steady state conditions with IC50 
levels of 49.09 and 27.13 μg/ml respectively. 
Standard ascorbic acid (ASC) under similar 
conditions showed an IC50 of 2.78 μg/ml (Table 
1). For stopped-flow kinetic spectrometric 
studies, the concentration of DPPH was kept at 
50 μM. In the presence of the extract/fraction the 
absorption due to the DPPH radical (monitored at 
517 nm) decayed completely in 50 seconds (Inset 
Figure 6).  This absorption-time plot was fitted to 
a single exponential function to obtain observed 
decay rate constant (kobs), which was found to 
increase linearly with DVW and DVE-4 
concentrations from 26-260 μg/ml. The kobs for 
the decay of DPPH radical in presence of DVW 
and DVE-4 at 130 μg/ml were found to be 0.133 
s-1 and 0.039 s-1 respectively (Figure 6).  
 
 
Figure 6. Variations of kobs for ABTS•− decay 
at 645 nm as a function of different 
concentrations of (a) DVW (b) DVE-4. Inset: 
absorption-time plot showing decay of 100 μM 
DPPH at 645 nm in presence of (c) 127.5 μg/ml 
of DVW (d) 130 μg/ml of DVE-4. 
 
Reaction with ABTS radical anion: Both DVW 
and DVE-4 were found to have comparable 
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ability to scavenge ABTS•− (100μM) under 
steady state conditions with an IC50 18.11 and 
20.12 μg/ml respectively. ASC showed an IC50 of 
1.64 μg/ml under the same experimental 
conditions (Table 1). For stopped-flow kinetic 
spectrometric studies, the concentration of 
ABTS•− was kept at 100 μM. In the presence of 
the extract/fraction, the absorbance of ABTS•− 
decayed completely in 20 seconds (Inset Figure 
7). This absorption time-plot was fitted to a single 
exponential function to get observed decay rate 
constant (kobs), which was found to increase with 
concentration of DVW and DVE-4 (26-260 
μg/ml). The kobs for the decay of ABTS•− in 
presence of DVW and DVE-4 at 130 μg/ml was 
found to be 6.36 s-1 and 0.39 s-1 respectively 
(Figure 7).  
 
 
Figure 7. The •OH scavenging ability of (a) 
DVW and (b) DVE-4 as determined by 
competition kinetics with KSCN, monitoring 
(SCN)2• − at 500 nm. Slope of this curve gives 
the rate constant. Inset shows absorption 
spectrum of transient species obtained by •OH 
attack on DVW and DVE-4 during pulse 
radiolysis of aqueous solutions containing 80 
μg/ml of (c) DVW and (d) DVE-4 at pH 6.8 and 
saturated with N2O. Dose per pulse = 18.5 Gy, 
spectra taken 10 μs after the pulse. 
 
Reaction with hydroxyl radical: DVW and DVE-
4 exhibited concentration dependent •OH 
(generated through Fenton reaction) scavenging 
with similar IC50 values of 279.95 and 279.27 
μg/ml respectively. Standard mannitol showed an 
IC50 of 2.95 mg/ml under the same experimental 
conditions (Table 1). The reactivity, in 
nanosecond time scales towards •OH, by both 
DVW and DVE-4 were studied using pulse 
radiolysis. Transient spectra showed a peak at 
310 nm (Inset Figure 8). The spectra do not 
indicate any detectable standard polyphenolic 
antioxidants such as gallic acid, flavonoids, 
which probably indicates the presence of low 
molecular weight phenolics. The ability of DVW 
and DVE-4 to scavenge •OH was determined by 
studying the competition kinetics with 250 μM 
KSCN towards •OH and monitoring the 
absorbance of the (SCN)2•− at 500 nm. 
Percentage relative rates of hydroxyl scavenging 
by DVW and DVE-4 in comparison to KSCN 
were calculated (Figure 8). DVW and DVE-4 
were found to be 0.064 and 0.088 times as 




Fig. 8. Calf thymus DNA protection studies by 
DVW and DVE-4. Lane 1: Control DNA; Lane 
2: Fenton reaction (FR) induced DNA damage; 
Lane 3: DVW and DNA; Lane 4: DVW+ DNA+ 
FR; Lane 5: DVE-4 and DNA; Lane 6: DVE-4+ 
DNA+ FR. 
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Table 2. Effect of DVW and DVE-4 on lipid profiles in normal and experimental diabetic animals 
[Multidose fifteen-day study] 
 
Each value represents Mean ± S.E.M., n=5. a p<0.05, b p<0.01 and c p<0.001 compared to diabetic control. 
One-way ANOVA followed by Tukey’s post-test. 
 
Lipid peroxidation assay: Table 1 shows the 
Inhibition of Fe3+/ascorbate induced lipid 
peroxidation in liposomes containing egg 
phospatidylcholine as assessed by the formation 
of TBARS by DVW and DVE-4 with IC50 68.02 
and 54.53 μg/ml respectively. The IC50 of Trolox 
under the same experimental conditions was 
found to be 7.99 μg /ml. 
Reaction with superoxide radical anion: 
Superoxide radical anion derived from dissolved 
oxygen by phenazine methosulphate-NADH 
coupling reaction reduces NBT+2 to NBT+1. The 
decrease in absorbance at 560nm with antioxidant 
indicates the quenching of O2•− in the reaction 
mixture. Both DVW and DVE-4 were found to 
have comparable O2•− scavenging ability under 
steady state conditions with an IC50 49.15 and 
47.08 μg/ml respectively. The IC50 of BHA under 
the same experimental conditions was found to be 
1.46 μg /ml (Table 1). 
Total antioxidant capacity: Both the tested 
extract and fraction were found to possess high 
antioxidant capacity (reduction of MoVI to MoV) 
of 0.94 and 1.05 mg of ASC equivalents per 
milligram of the DVW and DVE-4 respectively 
(Table 1). 
Calf thymus DNA Protection studies: DVW and 
DVE-4 did not damage the DNA themselves as 
indicated in lanes 3 and 5. Both DVW and DVE-
4 (800μg/ml) marginally protected the hydroxyl 
radical-induced DNA damage as evident from 
lane 4 and 6 respectively.  
 
Discussion 
Diabetes mellitus, a common heterogenous 
metabolic syndrome, is prevalent throughout the 
world and has been projected to become one of 
the world’s main cause of morbidity and 
mortality within the next 25 years [25]. 
Evaluation of plant products to treat diabetes 








































74.4±6.6 c 122.6±8.5 108.2±7.6 84.0±4.3 b 99.8±6.3 80.6±5.4 b 97.4±5.9 78.2±7.8 c 
HDL-c 
(mg/dl) 
29.0±3.3 c 16.2±1.3 16.8±2.4 24.0±2.6 17.2±1.9 26.2±2.0 21.4±2.5 27.4±3.7 a 
VLDL-c 
(mg/dl) 
14.3±1.1 c 28.2±1.6 19.9±1.4 b 16.9±1.6 c 18.4±1.7 b 14.7±1.6 c 18.1±1.7 c 15.2±1.3 c 
LDL-c 
(mg/dl) 
31.1±4.8 c 78.2±7.5 70.3±9.3 43.1±6.6 b 64.2±6.0 39.7±4.6 c 57.9±4.8 35.6±3.8 c 
TC/HDL-c 
ratio 
2.6±0.1 b 7.7±0.5 7.3±1.6 3.8±0.7 b 6.1±0.7 3.1±0.3 b 4.8±0.6 2.9±0.2 b 
TC/HDL-c 
ratio 
1.1±0.1 b 4.9±0.4 4.9±1.4 2.0±0.6 a 3.9±1.0 1.6±0.2b 2.9±0.5 1.3±0.1b 
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many bioactive substances with therapeutic 
potential. In recent years several authors 
evaluated the efficacy of different medicinal 
plants in the modulation of oxidative stress 
associated with diabetes mellitus [26-27]. To our 
knowledge, this is the first study in which a 
follow up was made on the effect of 
extract/fractions of D. viscosa on the levels of 
glucose, lipid profile, non-enzymatic and 
enzymatic antioxidants in STZ-induced diabetic 
animals. 
The present data indicates that D. viscosa 
extract/fraction significantly reduced 
hyperglycemia in both single dose and multidose 
diabetic studies. The efficacy of the 
extract/fraction is comparable to standard 
glibenclamide, and could be mediated by 
improving the glycemic control mechanisms and 
increasing insulin secretion from remnant 
pancreatic β-cells in diabetic rats. 
Diabetes mellitus is often linked with abnormal 
lipid metabolism. The impairment of insulin 
secretion results in enhanced metabolism of lipids 
from the adipose tissue to the plasma [28]. It has 
been demonstrated that insulin deficiency in 
diabetes leads to a variety of disruption in 
metabolic and regulatory processes, which in turn 
lead to accumulation of lipids [29]. It has also 
been shown that insulin significantly normalizes 
lipid levels in diabetic rats [30]. The extract 
supplementation also results in significant 
attenuation in serum TG, TC, VLDL-c, and LDL-
c. These effects may be due to low activity of 
cholesterol biosynthesis enzymes or low levels of 
lipolysis. Increased TC/HDL-c and LDL-c/HDL-
c ratios are well known markers of dyslipidemia 
in STZ-induced diabetic rats [31]. DVW and 
DVE-4 supplementation restored dyslipidemic 
markers to normal values. Therefore, 
normalization of lipids in diabetic rats treated 
with the Dodonaea viscosa may be partly due to 
its stimulatory effect on insulin secretion from 
pancreatic β-cells.     
Hyperglycemia is a well-known cause for 
elevated free radical concentration and this can 
lead to increased lipid peroxidation (TBARS). 
According to Randle’s glucose-fatty acid 
hypothesis, oxidation of excessive free fatty acid 
causes production of reactive oxygen species 
including hydrogen peroxide, which inhibit 
glucose utilization by the tissue. These reactive 
oxygen species may cause damage to cellular 
structures and impair glucose metabolism [32]. 
Elevated free radical concentration and lipid 
peroxidation decreases the antioxidant defense in 
the biological systems. Reduced glutathione 
(GSH) has an important role in the generation of 
cellular redox state and consequently, the 
imbalance in reduced glutathione to oxidized 
glutathione ratio is a putative indicator of cellular 
oxidative stress. The generation of oxygen 
radicals by increased levels of glucose causes 
tissue GSH depletion which attempts to 
overcome the deleterious effects of lipid 
peroxidation. Also glutathione peroxidase utilizes 
GSH as its cosubstrate while scavenging H2O2 
formed by the action of SOD. Therefore 
diminished levels of GSH were observed in 
untreated diabetic rats. Lowered levels of 
enzymatic antioxidants such as SOD, catalase and 
GST have been well documented in the diabetic 
condition [33]. Treatment with tested extract/ 
fraction combats the elevated levels of these 
enzymes, thereby indicating a protective effect. 
The phytochemical examination of polar fractions 
of D. viscosa revealed the presence of flavonoids, 
tannins, saponins and coumarins [9,34]. Several 
authors have reported flavonoids, phenolics and 
coumarins as bioactive antidiabetic principles 
[26,35]. The observed antioxidant and 
antidiabetic activity of title plant may be 
attributed to the presence of these bioactive 
principles and their synergistic properties. 
 
Conclusion 
The polar fraction of D. viscosa has potent 
antioxidant, antidiabetic and hypolipidaemic 
activity in STZ-induced diabetic rats. 
Collectively, these findings indicate that the 
antioxidant effects of polar fraction of the title 
plant may be an important contributor to its 
antidiabetic potential. The present investigation 
has also opened avenues for further research 
especially with reference to the development of 
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potent phytomedicine for diabetes mellitus from 
the Dodonaea viscosa.      
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